Memantine hydrochloride oral
Memantine Hydrochloride is a prescription oral solution (2 mg/mL) used to treat moderate to severe Alzheimer's disease. It works by regulating glutamate activity in the brain. Manufactured by Seton Pharmaceuticals under ANDA210319. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Memantine Hydrochloride is a prescription oral solution (2 mg/mL) used to treat moderate to severe Alzheimer's disease. It works by regulating glutamate activity in the brain. Manufactured by Seton Pharmaceuticals under ANDA210319. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Memantine hydrochloride oral",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Memantine hydrochloride oral — ANDA 210319 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210319"
}
]
|
| identifier | ANDA210319 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"health-care",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Memantine hydrochloride oral |
